Arcadia Biosciences, Inc.
RKDA- Exchange
- Nasdaq
- Industry
- Crude Petroleum & Natural Gas
- SEC CIK
- 0001469443
No open-market purchases or sales by Arcadia Biosciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $146.5K in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Arcadia Biosciences, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- −3 vs. Q1 2024
- Shares held
- 28.7K
- −52.3K (−64.5%) vs. Q1 2024
- Total value
- $90.4K
- −$87.9K (−49.3%) vs. Q1 2024
- New holders
- 2
- 1 more added
- Sold out
- 5
- 1 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RKDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $146.5K |
| Q1 2026 | 17 | $483.5K |
| Q4 2025 | 13 | $77.4K |
| Q3 2025 | 16 | $227.2K |
| Q2 2025 | 14 | $259.1K |
| Q1 2025 | 14 | $222.1K |
| Q4 2024 | 13 | $464.9K |
| Q3 2024 | 13 | $149.0K |
| Q2 2024 | 11 | $90.4K |
| Q1 2024 | 14 | $178.3K |
| Q4 2023 | 15 | $430.7K |
| Q3 2023 | 12 | $158.6K |
| Q2 2023 | 13 | $538.0K |
| Q1 2023 | 15 | $1.21M |
| Q4 2022 | 29 | $639.5K |
| Q3 2022 | 24 | $1.73M |
| Q2 2022 | 22 | $1.71M |
| Q1 2022 | 25 | $2.69M |
| Q4 2021 | 27 | $2.43M |
| Q3 2021 | 21 | $6.54M |
| Q2 2021 | 27 | $7.40M |
| Q1 2021 | 23 | $3.17M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Arcadia Biosciences, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 14,038 | $44.2K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 12,146 | $38.3K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,783 | $5.62K | 0.00% | −1,991−52.8% | Reduced |
| Morgan Stanley | 607 | $1.91K | 0.00% | +400+193.2% | Added |
| Advisor Group Holdings, Inc. | 88 | $276 | 0.00% | +88 | New |
| Group One Trading, L.P. | 18 | $57 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 11 | $35 | 0.00% | +11 | New |
| US Bancorp | 5 | $16 | 0.00% | 00.0% | Unchanged |
| Oliver Lagore Vanvalin Investment Group | 4 | $13 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 1 | $3 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Sabby Management, LLC | 0 | $0 | 0.00% | −40,300−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −10,453−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| VitalStone Financial, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |